A federal consider on Tuesday dismissed a lawsuit brought against Express Scripts by shareholders who accused the pharmaceutics benefits manager of inflating its share price by hiding its deteriorating relationship with its largest consumer, Anthem.
U.S. District Judge Edgardo Ramos in Manhattan, who dismissed an earlier variety of the lawsuit last August, said shareholders failed to support their requirement that Express Scripts knowingly misled them.